Cingulate, Inc. (CING)
4.26
+0.02
(+0.47%)
USD |
NASDAQ |
Nov 06, 16:00
4.25
-0.01
(-0.23%)
After-Hours: 20:00
Cingulate EPS Diluted (Quarterly) : -0.4452 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.4452 |
| March 31, 2026 | -0.9537 |
| December 31, 2025 | -0.8652 |
| September 30, 2025 | -1.352 |
| June 30, 2025 | -1.135 |
| March 31, 2025 | -1.056 |
| December 31, 2024 | -1.831 |
| September 30, 2024 | -2.336 |
| June 30, 2024 | -5.474 |
| March 31, 2024 | -7.213 |
| Date | Value |
|---|---|
| December 31, 2023 | -71.28 |
| September 30, 2023 | -72.60 |
| June 30, 2023 | -135.78 |
| March 31, 2023 | -84.99 |
| December 31, 2022 | -97.73 |
| September 30, 2022 | -85.46 |
| June 30, 2022 | -85.74 |
| March 31, 2022 | -106.18 |
| June 30, 2021 | -30.40 |
| March 31, 2021 | -28.31 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.510 |
| Corcept Therapeutics, Inc. | 1.010 |
| Veru, Inc. | -0.3032 |
| Johnson & Johnson | 0.0858 |
| Eli Lilly & Co. | 7.221 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.870M |
| Total Expenses (Quarterly) | 5.870M |
| Enterprise Value | 37.08M |
| Earnings Yield | -84.88% |
| Normalized Earnings Yield | -79.89 |